Fear of cancer recurrence after a reassuring scan

Uncertainty after cancer treatment

Recurrence remains possible for some people, so psychological treatment has to begin with an honest account of uncertainty. Surveillance can bring back memories of diagnosis and treatment, while a waiting room or a bodily sensation takes on meanings that it did not have before cancer.

Reassurance from a scan concerns what the investigation can establish at that point, leaving questions about the future unresolved. When those questions begin to govern daily life, the person may spend much of the time between appointments trying to obtain reassurance that medical surveillance cannot provide.

A 2025 systematic review of surveillance-associated anxiety after curative-intent cancer surgery found substantial variation in measurement, making prevalence estimates difficult to compare. The review identified the psychological burden of surveillance and gaps in targeted help, while leaving uncertainty about how often particular patterns occur.

Agreed monitoring and repeated checking

Monitoring symptoms should follow a plan agreed with the treating team, particularly about which changes need assessment and how to seek advice. Outside that plan, repeated body checking, online searches or requests for others to inspect a symptom may provide only brief relief.

Avoiding follow-up can also become a way of managing fear, although it carries different practical consequences. In either pattern, therapy can examine what happens before and after the response, including whether attention remains fixed on threat for longer or whether a feared appointment is repeatedly postponed.

Treatment may include a symptom-response plan, work with attention and a gradual reduction in unplanned checking. It can also address activities and goals that have been deferred while the person waits to feel sufficiently certain about their health.

Treatment findings and their limits

A 2024 network meta-analysis of randomised trials found that several non-drug approaches reduced fear of recurrence, although cancer types, interventions and follow-up periods varied. Cognitive-behavioural and metacognitive elements may help when they address worry, monitoring and the use of reassurance.

A 2026 randomised trial tested a culturally adapted ConquerFear program with 175 Chinese cancer survivors, addressing attention, metacognitive beliefs, acceptance, monitoring behaviour and goals. Participants improved more than those receiving survivorship care immediately after treatment and at three months, but the between-group difference was not significant at six months.

The result supports a short-term treatment benefit while leaving questions about maintaining improvement, including whether further sessions would help and how adaptation in the comparison group affected later differences. The findings also need to be considered in relation to the population and setting in which treatment was tested.

Living through the period between appointments

Cancer may change a person's trust in their body, relationships, work and sense of the future, while others expect them to feel only grateful that treatment has ended. Grief or anger can remain difficult to discuss when everyone around them is looking for reassurance that life has returned to normal.

Psychological work can make space for those responses while helping the person decide how to handle the next reminder, scan or symptom. A practical review might ask whether the agreed monitoring plan is being followed and whether fear is leaving more room for ordinary activities between appointments.